| Name |
Ragwizax 12 SQ-Amb sublingvalni liofilizat |
| Marketing Authorisation Number |
HR-H-040811656 |
| Active Substance |
standardizirani ekstrakt alergena peludi ambrozije |
| Composition |
standardizirani ekstrakt alergena peludi ambrozije (Ambrosia artemisiifolia), 12 SQ-Amb po sublingvalnom liofilizatu |
| Pharmaceutical Form |
Sublingvalni liofilizat |
| Manufacturer |
ALK-Abelló S.A., Madrid, Španjolska |
| Marketing Authorisation Holder |
ALK-Abelló A/S, Boge Allé 6-8, Horsholm, Danska |
| Marketing Authorisation Date |
15.07.2022 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/22-02/14 |
| Registration Number |
381-12-01/38-22-04 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product subject to restricted medical prescription
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
V01AA10 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
| Public Assessment Report |
download
|
